Search for: "Aventis Pharma S.A."
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
30 Aug 2009, 9:43 pm
Aventis Pharma S.A. et al. v. [read post]
29 Jan 2009, 9:59 pm
Noonan -- The Supreme Court was petitioned today to grant certiorari in two cases important to biotechnology patenting: In re Bilski, involving the standard for determining that method claims are patentable subject matter; and Aventis Pharma S.A. v. [read post]
9 Jan 2011, 9:09 pm
Aventis Pharma S.A. et al. v. [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendants: Apotex Corp.; Apotex Inc. [read post]
9 Apr 2012, 4:00 pm
In Aventis Pharma S.A. v. [read post]
6 Jan 2008, 9:07 pm
Aventis Pharma S.A. et al. v. [read post]
3 Apr 2019, 5:15 am
Court of Appeals for the Federal Circuit has referred to the defense of inequitable conduct as the “atom bomb of patent law” Aventis Pharma S.A. v. [read post]
9 Oct 2009, 8:14 am
In Aventis Pharma S.A. v. [read post]
27 Mar 2011, 10:07 pm
By Jason Rantanen Aventis Pharma S.A. v. [read post]
12 Sep 2021, 9:59 pm
Noonan -- Imposition of liability under the equitable doctrine of inequitable conduct (as it has been variously defined) can result in a patent being held unenforceable; for this reason, former Chief Judge Rader called it the "atomic bomb of patent law" (see Aventis Pharma S.A. v. [read post]
12 Apr 2012, 6:25 pm
Aventis Pharma S.A. et al. v. [read post]
29 Apr 2013, 8:36 am
Arguments not made in the parties opening briefs are ordinarily deemed waived, see Aventis Pharma, S.A. v. [read post]
3 Apr 2019, 5:15 am
Court of Appeals for the Federal Circuit has referred to the defense of inequitable conduct as the “atom bomb of patent law” Aventis Pharma S.A. v. [read post]
21 Apr 2014, 2:03 pm
According to the case, Sanofi-Aventis Deutschland GmbH is the owner of the patent at issue and Aventis Pharma S.A. is the exclusive licensee of that patent. [read post]
14 May 2008, 2:00 pm
More detail of Aventis Pharma S.A. v. [read post]
1 Jul 2009, 7:14 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Oct 2010, 3:37 pm
Aventis Pharma S.A. v. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
